Eloxx Pharmaceuticals (ELOX)

• Market cap: $59.9M
• 1 day: 31.05%
• 5 days: 47.84%
• 1 month: 25.58%
• 3 months: 58.31%
• 6 months: 58.31%
• Year to date: 58.31%
• 1 year: 58.31%
• 5 years: 58.31%
• 10 years: 58.31%
• Sector: Healthcare
• Industry: Biotechnology

About: Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Employees: 7